Live Vape Free": National Text-Based Program Targets Teen Vaping

Sep.09.2022
Live Vape Free": National Text-Based Program Targets Teen Vaping
Live Vape Free is a national text-based program providing free tools and resources to help teenagers quit vaping.

Live Vape Free is a nationwide free program that uses text messaging to provide tools and resources to help teenagers quit vaping. According to a recent study in the Journal of the American Medical Association, much of the progress made in helping children quit smoking over the past two decades may be slowly disappearing, as many young people are attempting but failing to quit using nicotine-containing e-cigarettes. Acting Secretary of Health David R. Scrase, MD, said, "This program will be a valuable tool in helping our young people quit e-cigarettes and provide educational resources for parents, guardians, and teachers.


The program is primarily aimed at teenagers aged 13 to 17 and offers one-on-one tutoring, on-site text support, and interactive content to help them quit smoking. "Live Vape Free" aims to help teenagers find their "reason" for quitting smoking by educating them on the key aspects of quitting and boosting the overall confidence of young people who want to quit.


By obtaining and maintaining a nicotine-free lifestyle, users are motivated and encouraged to learn more about the long-term impacts on their health.


New Mexico is one of only five states out of the 13 that use the Live Vape Free program to simultaneously launch both the youth and adult portions of the initiative. According to a press release on the Department of Health website, teenagers can easily register by texting VAPEFREE to 873373, while adults can sign up online at LiveVapeFreeNM.com.


Media headlines overshadow the potential of electronic cigarettes.


Meanwhile, a recent article published in the American Journal of Public Health highlights that the potential for quitting smoking through e-cigarettes has largely been overshadowed by media coverage of potential risks to adolescents.


Kenneth Warner, the distinguished University of Michigan School of Public Health's honorary dean and Avedis Donabedian honorary professor, along with 14 former presidents of the Nicotine and Tobacco Research Association, jointly wrote an article emphasizing the importance for the health industry to give attention to existing scientific data.


The article states that due to evidence suggesting that the use of e-cigarettes can increase the likelihood of quitting smoking, many scientists, including the author of this article, encourage the health industry, media, and policymakers to carefully consider the potential of e-cigarettes in reducing adult smoking mortality rates.


The author reviewed the health risks of e-cigarettes and their potential to help people quit smoking, while also addressing concerns about youth vaping. Taking all of these factors into consideration, they emphasized the need to balance any legitimate concerns about youth vaping with the potential benefits of the product for adults trying to quit smoking.


Statement


This article is compiled from third-party information and is intended only for industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is solely for industry exchange and research purposes.


Due to limitations in translation abilities, the compiled article may not fully convey the original author's expression. For accuracy, please refer to the original article.


2FIRSTS aligns completely with the Chinese government's position on any domestic issues, as well as those involving Hong Kong, Macau and Taiwan, and any matters involving foreign relations.


The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | ZAR Launches Coffee AirPouch, Expanding Pouch Format Into Caffeine Products
Product | ZAR Launches Coffee AirPouch, Expanding Pouch Format Into Caffeine Products
ZAR has introduced Coffee AirPouch, a nicotine-free caffeine pouch product that extends the brand’s AirPouch format into the functional consumer category. Each pouch contains 50mg of natural caffeine and features a coffee flavor, highlighting how pouch-based products are expanding beyond traditional nicotine applications into broader lifestyle and energy-use scenarios.
Market
Jul.13 by 2Firsts Perspectives
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia will place e-cigarettes and related nicotine products under its “strategic goods” framework from August 20, 2026. According to TVP World’s report published on August 19, the newly listed items include e-cigarettes, electronic smoking devices, vape liquids and nicotine salts. Individuals who illegally move these products across Russia’s customs border or its state border with other Eurasian Economic Union (EAEU) members could face up to five years in prison if shipment values exceed 100,000 rubles (about €1,000), provided all elements of a criminal offence are established.
Aug.20
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
A former FDA toxicologist has questioned whether the agency fully assessed the material used in ZYN nicotine pouches before authorizing them for sale, raising concerns over possible microplastic exposure, according to STAT and The Examination.
Jul.16
Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market
Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market
According to Haypp’s 2026 UK Nicotine Report, women are a key growth driver in the UK nicotine pouch market. Overall sales for Haypp and Northerner rose 60% year‑on‑year in 2025, but purchases by women surged 202%, versus 25% for men. Women’s share of consumers jumped from 22% to 40%. The report attributes this to discretion, perceived health benefits, and more gender‑neutral product positioning, suggesting future growth will come from a broader range of adult nicotine users.
Jul.01
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece have opposed Ireland’s proposed nicotine product regulations, arguing that the measures could affect EU market coordination and the free movement of products. Ireland plans to introduce stricter rules covering nicotine products including vapes and nicotine pouches, with measures involving packaging, marketing and sales controls. The dispute highlights differences among EU member states between stronger public health protections and maintaining regulatory consistency within the bloc’s single market.
Jul.29